Preoperative Tislelizumab -Cetuximab - Chemotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab -Cetuximab for Resectable, Locally Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma

Name: Preoperative Tislelizumab -Cetuximab - Chemotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab -Cetuximab for Resectable, Locally Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma
License: Public Domain

Shanghai Zhongshan Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

oral squamous cell carcinoma (oscc), oropharyngeal squamous cell carcinoma (scc), resectable oral and oropharyngeal squamous cell carcinoma, recurrent oral and oropharyngeal squamous cell carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 272363
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.